Jia Jiaya, a tenured professor at the Chinese University of Hong Kong and a top expert in computer vision and artificial intelligence. With more than 20 years of research experience, he deployed advanced technology to support social development. He has led his team to develop well-known new generation of advanced manufacturing platform, auto-driving platform, and intelligent medical diagnosis system.

In 2010, Prof Siew Ng, a specialist in gastroenterologist, met Prof Francis Chan, Dean of Faculty of Medicine, the Chinese University of Hong Kong. There came the opportunity of InnoHK, the major initiative of the Government for global research collaboration, to position Hong Kong as a leading biotech hub. They convinced the Innovation and Technology Bureau with their proposal and successfully established Microbiota I-Center (MagIC), the only microbiome R&D center in Asia. In 2019, along with Prof Francis Chan, she co-founded GenieBiome (G-Niib) Limited.

Co-founded in 2019 by Dr Tenny Lam, Doctor of Business Administration, and Prof Pei Li, Department of Applied Biology and Chemical Technology of the Hong Kong Polytechnic University. Grand Rise Technology Limited (“Grand Rise Technology”) developed a novel bio-based technology based on the patented core-shell particle technology platform, enabling a new class of amphiphilic core-shell nanoparticles for a wide range of applications such as bio-based anti-microbial coating applications solutions and edible coating for food shelf-life extension.

Mr Leung has over 10 years’ experience in the life science and finance industries. Currently, he is the Chairman of Great Bay Bio (“GBB”) and also serves as Director in both Uni-bio Science Group and DotBio. He was also elected the Vice Chairman of Pharmaceutical & Chemical group of the Federation of Hong Kong Industries. GBB, headquartered in Hong Kong, was founded in 2019 with extensive footprint in the Greater Bay Area. The core team of GBB is composed of global talents with expertise in medicine, pharmacy, synthetic biology and AI.

Dr Ricky Chiu has been recognised as being one of the top leaders in the biotechnology field in Hong Kong. He has developed a proprietary sample preparation technology that significantly improves the speed and accuracy of diagnostic testing, thus enabling much earlier detection of cancers and infectious diseases. As a scientist who deeply cares about public health, Dr Chiu’s dedication to corporate social responsibility goes beyond his company.

Founded in 1989, Biel Crystal Holdings Limited (Biel) is a leading global provider of exterior structure and module solutions for smart devices. With over 30 years of technological innovation and excellent management, Biel has become a large technology innovation group with 8 advanced production bases worldwide, a total capital investment of over HK$40 billion, a total area of industrial zones reaching approximately 2 million square meters, over 80,000 employees, and an annual production capacity of 1.85 billion pieces.

Founded in 2014, Prenetics Global Limited (“Prenetics”) is a global leading diagnostics and genetic testing company with the mission to build the world’s first end-to-end health ecosystem by placing online and offline clinical care in consumers’ control, across consumer health, medical and cancer genomics.

Alibaba Hong Kong Entrepreneurs Fund (AEF) is a not-for-profit initiative launched by Alibaba Group in 2015. Mission is to support young entrepreneurs in Hong Kong to fulfil their startup dreams, while contributing to the community. Meanwhile, exploiting a pioneering and sustainable model, aspire to bolster innovation and entrepreneurship in order to help Hong Kong stay vibrant and emerge as an international innovation and technology hub.